---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-041006"
form_type: "8-K"
ticker: "NTRB"
cik: "0001676047"
company_name: "NutriBand Inc."
filed_at: "2026-04-07T23:59:59+00:00"
generated_at: "2026-05-15T07:03:11.061289+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nutriband selects brand name for abuse-deterrent fentanyl patch; will submit to FDA

## Summary
- Selected commercial worldwide brand name candidate for lead product, a fentanyl transdermal system with abuse-deterrent technology.
- Will submit proposed brand name and labeling to FDA and international regulators for review and approval; also filing for trademark registration.
- Engaged Brand Institute, global leader with 75% share of drug name approvals and 87% of FDA-approved names in 2024.
- Product uses AVERSA abuse-deterrent technology; potential peak annual US sales of $80-200 million per market report.
- Brand Institute's regulatory subsidiary DSI, led by former FDA/EMA officials, will provide regulatory support.

## SEC filing metadata
- accession: 0001213900-26-041006
- form_type: 8-K
- ticker: NTRB
- cik: 0001676047
- company_name: NutriBand Inc.
- filed_at: 2026-04-07T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676047/000121390026041006/0001213900-26-041006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676047/000121390026041006/ea0285330-8k_nutriband.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-041006
- JSON: https://secwatch.observer/filing/0001213900-26-041006.json
- Plain text: https://secwatch.observer/filing/0001213900-26-041006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
